ロード中...
Antifibrinolytic therapy in cardiac surgery.
Bleeding remains an important complication after repeat and complicated cardiac surgery. Although aprotinin has recently been approved by the Food and Drug Administration for use as an antifibrinolytic agent, many surgeons continue to have concerns about its added cost and potential side effects. We...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1995
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC325256/ https://ncbi.nlm.nih.gov/pubmed/7580358 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|